Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02953392 · ClinicalTrials.gov registry record · NA
Implant-Abutment Interface Design on Bone and Soft Tissue Levels Around Implants Placed Using Different Transcrestal Sinus Floor Elevation
A NA study, sponsored by NYU College of Dentistry.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT02953392 is a NA study that has completed, run by NYU College of Dentistry. The registered enrollment target is 38 participants.
The verdict
NCT02953392, a NA study, has completed, sponsored by NYU College of Dentistry.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Sixty patients with partially edentulous posterior maxilla requiring a transcrestal sinus floor elevation technique to insert one implant will be selected. The purpose of this multi-center, prospective, double blind, and randomized investigation is to analyze a platform switched implant when placed at limited maxillary residual bone height with low bone density compared to a platform matching implant with or without bone graft material.
Interventions
- DEVICE Anorganic Bovine Bone Graft Material
- DEVICE Collagen Membrane
- DEVICE Shelta Platform Switching Premium Implants
- DEVICE Shelta Platform Matching Premium Implants
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2016-05-10 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02953392
The ClinicalTrials.gov registry entry for NCT02953392 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU College of Dentistry, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Anorganic Bovine Bone Graft Material is the first listed.
NCT02953392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02953392 about?
NCT02953392 is a clinical study titled "Implant-Abutment Interface Design on Bone and Soft Tissue Levels Around Implants Placed Using Different Transcrestal Sinus Floor Elevation". Sixty patients with partially edentulous posterior maxilla requiring a transcrestal sinus floor elevation technique to insert one implant will be selected. The purpose of this multi-center, prospective, double blind, and randomized investigation is to analyze a platform switched implant when placed ...
What is the current status of trial NCT02953392?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2016-05-10. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT02953392?
The interventions under investigation include: Anorganic Bovine Bone Graft Material (DEVICE), Collagen Membrane (DEVICE), Shelta Platform Switching Premium Implants (DEVICE), Shelta Platform Matching Premium Implants (DEVICE).
Who is sponsoring clinical trial NCT02953392?
This trial is sponsored by NYU College of Dentistry, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.